These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14660009)

  • 1. The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress.
    Scribner AW; Loscalzo J; Napoli C
    Eur J Pharmacol; 2003 Dec; 482(1-3):95-9. PubMed ID: 14660009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.
    Napoli C; Bruzzese G; Ignarro LJ; Crimi E; de Nigris F; Williams-Ignarro S; Libardi S; Sommese L; Fiorito C; Mancini FP; Cacciatore F; Liguori A
    Am Heart J; 2008 Dec; 156(6):1154.e1-8. PubMed ID: 19033012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
    de Nigris F; D'Armiento FP; Somma P; Casini A; Andreini I; Sarlo F; Mansueto G; De Rosa G; Bonaduce D; Condorelli M; Napoli C
    Int J Cardiol; 2001 Dec; 81(2-3):107-15; discusssion 115-6. PubMed ID: 11744122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.
    Mak IT; Freedman AM; Dickens BF; Weglicki WB
    Biochem Pharmacol; 1990 Nov; 40(9):2169-75. PubMed ID: 2173602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfur-containing angiotensin-converting enzyme inhibitor 3-thienylalanine-ornithyl-proline activates endothelial function and expression of genes involved in Renin-Angiotensin system.
    Chaudhary S; Seth MK; Vats ID; Kumar K; Biswas P; Karar J; Hussain ME; Pasha MA; Pasha S
    J Cardiovasc Pharmacol; 2013 Apr; 61(4):311-7. PubMed ID: 23232842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of angiotensin converting enzyme inhibitors on oxidative stress, endothelial function in patients with myocardial infarction].
    Zdionchenko VS; Leksina KS; Timofeeva NIu; Shekhian GG; Bagatyrova KM; Mironova MA
    Kardiologiia; 2009; 49(7-8):32-7. PubMed ID: 19656104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE-inhibition ameliorates vascular reactivity and delays diabetes outcome in NOD mice.
    Bucci M; Roviezzo F; Brancaleone V; Di Lorenzo A; Evangelista S; Gori M; Cirino G
    Vascul Pharmacol; 2008; 49(2-3):84-90. PubMed ID: 18606247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of angiotensin converting enzyme inhibitors with and without the SH-radical.
    Nakagawa M; Kobayashi K; Sawada S; Toyoda T; Shirai K; Katoh K; Yamamoto K; Tsuji H; Sasaki S; Takeda K
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):54S-55S. PubMed ID: 1848988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril.
    Evangelista S; Manzini S
    J Int Med Res; 2005; 33(1):42-54. PubMed ID: 15651714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition.
    Gómez-Roso M; Montero MJ; Carrón R; Sevilla MA
    J Pharm Pharmacol; 2016 Nov; 68(11):1422-1429. PubMed ID: 27670145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH
    Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk.
    Donnini S; Terzuoli E; Ziche M; Morbidelli L
    J Pharmacol Exp Ther; 2010 Mar; 332(3):776-84. PubMed ID: 19959747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.